AG00397J

13292-46-1 | 3-(((4-Methyl-1-piperazinyl)imino)-methyl)rifamycin

Chemical structure of 3-(((4-Methyl-1-piperazinyl)imino)-methyl)rifamycin, CAS 13292-46-1
AG00397J
sdsSDS
sdsCOA
TIP This product is typically in stock.Please contact us for quotation.
Request For Quotation

CAS Number 13292-46-1
Catalog Number AG00397J(AGN-PC-00S7WO)
Chemical Name 3-(((4-Methyl-1-piperazinyl)imino)-methyl)rifamycin
EC Number 236-312-0
IUPAC Name [(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-26-[(E)-(4-methylpiperazin-1-yl)iminomethyl]-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate
InChI InChI=1S/C43H58N4O12/c1-21-12-11-13-22(2)42(55)45-33-28(20-44-47-17-15-46(9)16-18-47)37(52)30-31(38(33)53)36(51)26(6)40-32(30)41(54)43(8,59-40)57-19-14-29(56-10)23(3)39(58-27(7)48)25(5)35(50)24(4)34(21)49/h11-14,19-21,23-25,29,34-35,39,49-53H,15-18H2,1-10H3,(H,45,55)/b12-11+,19-14+,22-13-,44-20+/t21-,23+,24+,25+,29-,34-,35+,39+,43-/m0/s1
InChI Key JQXXHWHPUNPDRT-WLSIYKJHSA-N
MDL Number MFCD00151389
Molecular Formula C43H58N4O12
Molecular Weight 822.9402
NSC Number 113926
SMILES OC1=C(/C=N/N2CCN(C)CC2)C3=C(O)C4=C(O)C(C)=C(O[C@@](O/C=C/[C@H](OC)[C@@H](C)[C@@H](OC(C)=O)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)/C=C/C=C(C)/C(N3)=O)(C)C5=O)C5=C41
UNII VJT6J7R4TR
Synonyms
Benemycin, Rifadin, Rifampicin, Rifampin, Rimactan, Rimactane, Tubocin, Rifampicin, rifampin, Rifadin, Rimactane, Rimactan, Rifamycin AMP, Rifaldazine, Rifampicinum, Rifaprodin, Riforal, Tubocin, Rifa, 13292-46-1, Archidyn, Rifoldin, Rifoldine, Rimactizid, Rifagen, Rimazid, Rifampicin SV, R/AMP, Rifampicina, Arficin, Benemicin, Doloresum, Eremfat, Fenampicin, Rifadine, Rifaldazin, Rifaldin, Rifamor, Rifinah, Rifobac, Rimactazid, Sinerdol, Arzide, Rifcin, Rifam, L-5103 Lepetit, Dione 21-acetate, Rifampicine [French], Abrifam, Rifampicinum [INN-Latin], Ba 41166/E, Rifampicina [INN-Spanish], 3-(((4-Methyl-1-piperazinyl)imino)methyl)rifamycin SV, CCRIS 551, Rifadin I.V., HSDB 3181, UNII-VJT6J7R4TR, BA-41166E, NSC113926, VJT6J7R4TR, Rifampicine, Rifampicin [INN:BAN:JAN], Rifamycin, 3-(((4-methyl-1-piperazinyl)imino)methyl)-, RFP, CHEBI:28077, 3-(4-Methylpiperazinyliminomethyl)-rifamycin SV, 8-(4-Methylpiperazinyliminomethyl) rifamycin SV, L-5103, C43H58N4O12, EINECS 236-312-0, Rifamate, NSC 113926, NSC-113926, 8-(((4-Methyl-1-piperazinyl)imino)methyl)rifamycin SV, Rifamycin, 3-[[(4-methyl-1-piperazinyl)imino]methyl]-, Rifomycin SV, 8-(N-(4-methyl-1-piperazinyl)formidoyl)-, DSSTox_CID_1244, DSSTox_RID_76035, DSSTox_GSID_21244, (2S,12Z,14E,16S,17S,18R,19R,20R,21S,22R,23S,24E)-5,6,9,17,19-pentahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-{(E)-[(4-methylpiperazin-1-yl)imino]methyl}-1,11-dioxo-1,2-dihydro-2,7-(epoxypentadeca[1,11,13]trienoimino)naphtho[2,1-b]furan-21-yl acetate, Famcin, RIF, Benemycin, (7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-26-{(E)-[(4-methylpiperazin-1-yl)imino]methyl}-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.1(4,7).0(5,28)]triaconta-1(28),1(29),2,4,9,19,21,25,27-nonaen-13-yl acetate, 5,6,9,17,19,21-Hexahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-(N-(4-methyl-1-piperazinyl)formimidoyl)-2,7-(epoxypentadeca(1,11,13)trienimino)naphtho(2,1-b)furan-1,11(2H)-dione 21-acetate, CAS-13292-46-1, 3-(4-Methylpiperazinyliminomethyl)rifamycin SV, 3-(((4-Methyl-1-piperazinyl)imino)-methyl)rifamycin, 3-[[(4-Methyl-1-piperazinyl)imino]-methyl]rifamycin, 3-([(4-Methyl-1-piperazinyl)imino]methyl)rifamycin SV, 8-[[(4-Methyl-1-piperazinyl)imino]methyl]rifamycin sv, rifamcin, [1,11,13]trienimino)naphto[2,1-b]furan-21-yl acetate, Rifomycin sv, 8-[N-(4-Methyl-1-piperazinyl)formidoyl]-, JQXXHWHPUNPDRT-WLSIYKJHSA-N, Rifamsolin, Dipicin, Rimycin, DRG-0109, MFCD00151389, MMV688775, Rifamicin AMP, Rifadin I.V, Rimactane (TN), NCGC00094777-01, AZT + Rifampin, Rifampin (USP), (2S,12Z,14E,16S,17S,18R,19R,20R,21S,22R,23S,24E)-5,6,9,17,19-Pentahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-[[(4-methylpiperazin-1-yl)imino]methyl]-1,11-dioxo-1,2-dihydro-2,7-(epoxypentadeca, (2S,12Z,14E,16S,17S,18R,19R,20R,21S,22R,23S,24E)-5,6,9,17,19-pentahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-{(E)-[(4-methylpiperazin-1-yl)imino]methyl}-1,11-dioxo-1,2-dihydro-2,7-(epoxypentadeca[1,11,13]trienoimino)naphtho[2,1-b]furan-21-yl acet, (2S,14E,16S,17S,18R,19R,20R,21S,22R,23S,24E)-5,6,9,17,19-Pentahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-{[(4-methylpiperazin-1-yl)imino]methyl}-1,11-dioxo-1,2-dihydro-2,7-(epoxypentadeca[1,11,13]trienoimino)naphtho[2,1-b]furan-21-yl acetate, [pentahydroxy-methoxy-heptamethyl-[(E)-(4-methylpiperazin-1-yl)iminomethyl]-dioxo-[?]yl] acetate, Rifampicin & EEP, Rifampin [USAN], Prestwick_833, R-Cin, Rifadin (TN), Piperine & Rifampicin, Rifampicin & Propolis, Reserpine & Rifampicin, Rifampin [USAN:USP], Prestwick2_000525, Prestwick3_000525, Spectrum5_002018, Rifampicin (JP17/INN), SCHEMBL23490, BSPBio_000509, L-5103-LEPETIT, 8CI), BPBio1_000561, CHEMBL374478, DTXSID6021244, HMS1569J11, HMS2089F12, HMS2096J11, HMS3713J11, Rifampicin, >=97.0% (HPLC), Rifampicin, powder, gamma-irradiated, Tox21_111329, Tox21_201385, Tox21_300550, Ba 41166, BDBM50370232, GR-306, AKOS015951372, Rifampicin, >=97% (HPLC), powder, Tox21_111329_1, BA-411661E, CCG-208267, DB01045, LS-7689, NCGC00022678-03, NCGC00022678-04, NCGC00022678-05, NCGC00022678-06, NCGC00179536-02, NCGC00254537-01, NCGC00258936-01, BC205696, M880, ST057531, AB1009526, C06688, D00211, J10110, Rifampicin, VETRANAL(TM), analytical standard, AB00383022_07, 292R461, SR-05000002118, 8-[[(4-Methyl-1-piperazinyl)imino[methyl]rifamycin, 8-[[(4-Methylpiperazinyl)imino]methyl]rifamycin sv, SR-05000002118-3, WLN: V1 WQ A&1 E&1 E1UN- AT6N DNTJ D1, 3-[(4-Methyl-1-piperazinyl)iminomethyl]rifamycin SV, Rifampicin, European Pharmacopoeia (EP) Reference Standard, Rifampin, United States Pharmacopeia (USP) Reference Standard, Rifampin, Pharmaceutical Secondary Standard; Certified Reference Material, 4,7>.0<5,28>]triaconta-1(28),2,4,9,1 9,21,25(29),26-octaen-13-yl acetate, Rifampicin, plant cell culture tested, BioReagent, >=97% (HPLC), crystalline, yl]-, (2S,12Z,14E,16S,17S,18R,19R,20R,21S,22R,23S,24E)-, (2S,12Z,14E,16S,17S,18R,19R,20R,21S,22R,23S,24E)-5,6,9,17,19-pentahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-{(E)-[(4-methylpiperazin-1-yl)imino]methyl}-1,11-dioxo-1,2-dihydro-2,7-(epoxypentadeca[1,11,13]trienoimino)naphtho[2,1-b]furan-21-yl ac, 2,11,13]trienimino)naphtho[2,1-b]furan-1,11(2H)-dione, 5,6,9,17,19,21-hexahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-[N-(4-methyl-1-piperazinyl)formimidoyl]-, 21-acetate, 2,7-(epoxy[1,11,13]pentadecatrienoimino)naphtho[2,1-b]furan-1,11(2H)-dione, 21-(acetyloxy)-5,6,9,17,19-pentahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-[(E)-[(4-methyl-1-piperazinyl)imino]meth, 2,7-(Epoxypentadeca(1,11,13)trienimino)naphtho(2,1-b)furan-1,11(2H)-dione, 5,6,9,17,19,21-hexahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-(N-(4-methyl-1-piperazinyl)formimidoyl)-, 21-acetate, 2,7-(Epoxypentadeca(1,11,13)trienimino)naphtho(2,1-b)furan-1,11(2H)-dione, 5,6,9,17,19,21-hexahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-(N-(4-methyl-1-piperazinyl)formimidoyl)-, 21-acetate (, 2,7-(Epoxypentadeca(1,11,13)trienimino)naphtho(2,1-b)furan-1,11(2H)-dione, 5,6,9,17,19,21-hexahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-(N-(4-methyl-1-piperazinyl)formimidoyl)-, 21-acetate (8CI), 26-[(1E)-2-(4-methylpiperazinyl)-2-azavinyl](7S,11S,13S,17S,18S,12R,14R,15R,16 R)-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-d ioxo-8,30-dioxa-24-azatetracyclo[23.3.1.1<, 5,6,9,17,19,21-Hexahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-(N-(4-methyl-1-piperazinyl)formimidoyl)-2,7-(epoxypentadeca(1,11,13)trienimino)naphtho(2,1-beta)furan-1,11(2H)-dione 21-acetate, 5,6,9,17,19,21-hexahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-[N-(4-methyl-1-piperazinyl)formimidoyl]-, 21-acetate, RMP, Stereoisomer of 5,9,17,19,21-Hexahydroxy-23-methoxy-2,4,12,16,18,20,22-he@ptamethyl-8-[N-(4-methyl-1-piperazinyl)formimidoyl]-2,7-(epoxypentadeca[1,11,13]trienimino)naphtho[2,1-b]furan-1,11(2H)-dione 21-acetate, Ramp, Rifater, null, Refampicin, Mixture Name, Rifampicin 1g, Rifampin/Rifampicin, RIFAMYCIN, Unable to generate value, Rifampicin, 98% - 5G 5g, D012293, 38776-75-9, 6998-60-3, Rf, RIP,

Related Research Chemicals

CERTIFICATE OF ANALYSIS
Chemical Name: Batch Number:
Chemical Structure: CAS Registry No:
Product ID:
Manufacture Date:
Storage Temperature:
Formula:
Molecular Weight:
Quantity:
Analysis Data:
Test: Result:
Conclusion: The above product meets the specifications of Angene.
Analyst:Chase
Date:
Reviewed by:Jessie
Date:
Angene International Limited